zourunan MULTI-PURPOS TREATMENT

Manufacturer
Guchutang Biotechnology (Longyan) Co., Ltd
Effective date
2025-10-22
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:40:48

Label at a glance#

Productzourunan MULTI-PURPOS TREATMENT
Active ingredientTOLNAFTATE
Label structure13 sections

Dosage and administration

For athlete's foot and ring worm: use daily for 4 weeks. Clean the affected area and dry thoroughly. Apply a thin layer of the product over affected area twice daily(morning and night) or as directed by a doctor. Supervise child ren in the use of this product. This product is not effective for the treatment of ring worm of the scalp or nails.

Storage and handling

Store at room temperature 15-30℃(59-86℉)

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION


Tolnaftate 1%

Purpose

OTC - PURPOSE SECTION

Antifungal

Use

INDICATIONS & USAGE SECTION

Cures most Athlete's Foot (Tinea Pedis) and Ringworm (Tinea Corporis).
Relieves itching, scaling, cracking, burning.
redness, soreness, and Irritation and discomfort.
Helps prevent most athlete's foot (dermatophytosis) with daily use.

Warnings

WARNINGS SECTION

For external use only.

Do not use

OTC - DO NOT USE SECTION

on Children under 2 years of age unless directed by a doctor.

When Using

OTC - WHEN USING SECTION

When using this product avoid contact with eyes.

Stop Use

OTC - STOP USE SECTION

Irritation occurs, there is no Improvement with in 4 weeks (for athlete's foot and ringworm).

Ask Doctor

OTC - ASK DOCTOR SECTION

Irritation occurs, there is no Improvement with in 4 weeks (for athlete's foot and ringworm).

Keep Out Of Reach Of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

For athlete's foot and ring worm: use daily for 4 weeks.

Clean the affected area and dry thoroughly.

Apply a thin layer of the product over affected area twice daily(morning and night) or as directed by a doctor. Supervise child ren in the use of this product.

This product is not effective for the treatment of ring worm of the scalp or nails.

Other information

STORAGE AND HANDLING SECTION

Store at room temperature 15-30℃(59-86℉)

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water, Ethanol, PEG-40 hydrogenated castor oil, Caramel color, Polysorbate -20.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
313423tolnaftate 1 % Topical SolutionPSN1
313423tolnaftate 10 MG/ML Topical SolutionSCD1
313423tolnaftate 1 % Topical SolutionSY1

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
87083-001-01zourunan MULTI-PURPOS TREATMENT30 mL in 1 BOTTLELIQUID301

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87083-00187083-001-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
zourunan MULTI-PURPOS TREATMENTMULTI-PURPOS TREATMENTGuchutang Biotechnology (Longyan) Co., Ltd41bad254-b674-9521-e063-6294a90ab6342025-10-22WarningsExact identifier
ndc (package): 87083-001-01
ndc (product): 87083-001
ndc11 (package): 87083000101
spl id: 41bad254-b675-9521-e063-6294a90ab634
spl set id: 41bad254-b674-9521-e063-6294a90ab634

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.